Investors currently investing in Miracor are:
Earlybird Venture Capital
Earlybird Venture Capital was established in 1997 and is one of the most successful European venture investors. Currently, Earlybird manages over 400 million Euros of assets. Earlybird invests in innovative, fast growing companies with outstanding management teams and high growth potential on international markets within the sectors software, semi-conductor technology, information and communication technology, internet based services, cleantech and medtech. Earlybird’s portfolio includes more than 21 companies in seven countries (Germany, Switzerland, Sweden, UK, USA, Italy and France). Since inception Earlybird has invested in more than 55 companies. Earlybird supports and accelerates entrepreneurial success. As one of the leading early stage venture capital investors in Europe, Earlybird offers entrepreneurs profound experience in setting up young businesses and supporting companies from the cradle to profitability: Earlybird does not only offer capital in the start-up-phase but also supports financing in later growth phases.
Delta Partners is a venture capital firm investing in Ireland and the United Kingdom. It was established in 1994 and has €230 million under management. The firm has a strong focus on investing in early stage technology companies, and the team has made over 50 investments in the following sectors: Information Technology; Communications; and, Healthcare. Delta Partners is among the most active early stage investors in Europe. The partners’ backgrounds in operations, strategy and finance complement the drive and ambition of entrepreneurial management teams. The firm has offices in Dublin and London.
SHS Gesellschaft für Beteiligungsmanagement mbH
The Tübingen-based investment company SHS Gesellschaft für Beteiligungsmanagement invests in medical technology and life science companies with a key focus on expansion financing, change of control and succession situations. SHS acquires both minority and majority investments. Founded in 1993, SHS is an experienced sector investor that supports its portfolio companies with a cooperative network for launching new products, with regulatory matters, or in entering additional markets. Among the national and international investors in SHS funds are the European Investment Fund, professional pension schemes, funds-of-funds, family offices, entrepreneurs, and the SHS management team. The AIFM-registered company is currently investing funds from the fourth generation of funds, for which its investors have provided € 125 million. The company makes equity investments of up to € 20 million. Transactions on a medium double-digit million scale can be performed together with a network of co-investors. SHS’s Managing Partners are Reinhilde Spatscheck, Dr. Bernhard Schirmers, Hubertus Leonhardt, and Uwe Steinbacher.
Here you find an overview of SHS’s current portfolio companies. Further information about SHS at: www.shsvc.net.
BioMedPartners is one of the leading European venture capital firms providing private equity and mezzanine financing to early- and mid-stage healthcare and human life science companies. The BioMedInvest vehicle targets the entire industry with special focus on pharmaceuticals, biotechnology, diagnostics and medical technology. Based in Basel, BioMedPartners has successfully invested in about 50 human life science companies over the last ten years, of which a large number have already been listed on the stock exchange or have been acquired by leading players in the pharmaceutical industry.
aws Founders Fund
aws Gründerfonds is Austria´s most active venture capital investor with investible assets of EUR 68.5 million made available by the Republic of Austria and Erste Bank. The fund invests up to EUR 3 million in early stage companies with high growth potential. Since its foundation in 2013, ten investments have already been completed and more than 600 business plans examined. The aws Gründerfonds is a subsidiary of the Austria Wirtschaftsservice Gesellschaft m.b.H.
Peppermint VenturePartners is a private venture capital firm based in Berlin, investing in early-stage companies in the healthcare sector. It focuses on companies that stand out as a result of their innovative ideas in the fields of medical technology, diagnostics and digital health, as well as biomedical platform technologies.